Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Serotonin Syndrome × Clear all

Phase

Status

Sponsor Class

OTHER 12 INDUSTRY 8 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 226 Leukemia 147 Carcinoma, Non-Small-Cell Lung 138 Lymphoma 128 Lung Neoplasms 123 Prostatic Neoplasms 109 Colorectal Neoplasms 102 Precursor Cell Lymphoblastic Leukemia-Lymphoma 101 Sarcoma 96 Ovarian Neoplasms 96 Central Nervous System Neoplasms 91 Multiple Myeloma 84 Head and Neck Neoplasms 83 Leukemia, Myeloid, Acute 73 Rectal Neoplasms 72 Squamous Cell Carcinoma of Head and Neck 71 Colonic Neoplasms 64 Neoplasm Metastasis 61 Brain Neoplasms 56 Uterine Cervical Neoplasms 55 Neuroblastoma 54 Carcinoma, Ovarian Epithelial 54 Fallopian Tube Neoplasms 53 Neoplasms 52 Melanoma 52 Lymphoma, Large B-Cell, Diffuse 51 Astrocytoma 49 Leukemia, Lymphocytic, Chronic, B-Cell 47 Hodgkin Disease 47 Glioblastoma 46

Interventions

telotristat ethyl 1 lanreotide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04065165 2020-02-05

TELEFIRST

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Withdrawn

Carcinoid Heart Disease, Serotonin Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡